Association of the AChRα-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients

Journal of Autoimmunity

Volumn 10, Issue 4, 1997, Pages 407-413

  Djabiri, Farid ^a   Caillat Zucman, Sophie ^a   Gajdos, Philippe ^b   Jaïs, Jean Philippe ^c   Gomez, Lucienne ^a   Khalil, Iman ^d   Charron, Dominique ^d   Bach, Jean François ^a   Garchon, Henri Jean ^a  

^a INSERM   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c Lab Bioinformatique et Inst Necker   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

DQA1; DR3; Ecetylcholine receptor; Genetics; Myasthenia gravis

Indexed keywords

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; FEMALE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; PRIORITY JOURNAL; BIOLOGICAL MODEL; CASE CONTROL STUDY; CHEMISTRY; GENE; GENETIC LINKAGE; GENETICS; IMMUNOLOGY; METABOLISM;

CHOLINERGIC RECEPTOR; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DR3 ANTIGEN; MICROSATELLITE DNA;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENES, MHC CLASS II; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR3 ANTIGEN; HUMANS; LINKAGE (GENETICS); MALE; MICROSATELLITE REPEATS; MODELS, GENETIC; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC;

EID: 0031195502     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0140     Document Type: Article

References (51)

1. Willcox N. Myasthenia gravis. Curr. Opin. Immunol. 5:1993;910-917.
2. Drachman D.B. Medical progress - myasthenia gravis. N. Engl. J. Med. 330:1994;1797-1810.
3. Fritze D., Herrman C.J.R., Naeim F., Smith G.S., Walford R.L. HL-A antigens in myasthenia gravis. Lancet. 1:1974;240-242.
4. Dawkins F.L., Christiansen F.T., Kay P.H., Garlepp M., McCluskey J., Hollingsworth P.N., Zilko P.J. Disease associations with complotypes, supratypes and haplotypes. Immunol. Rev. 70:1983;1-22.
5. Bell J., Rassenti L., Smoot S., Smith K., Newby C., Hohlfeld R., Toyka K., McDevitt H., Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet. 1:1986;1058-1060.
6. Dawkins R.L., Hawkins B.R., Gin W., Zhang W.J., Martin E., Christiansen F.T. Association between myasthenia gravis and HLA Bw46, BfS, C4A4, C4B2, DRw9 in Chinese. Immunobiology of HLA. Vol. I. 1989;Springer Verlag, New York.
7. Gin W., Dawkins R.L., Albert E.D., Hawkins B.R., Muller C., Tsuji K., Jeannet M., Schalke B. Myasthenia gravis: joint report. Immunobiology of HLA. Vol. I. 1989;Springer Verlag, New York.
8. Matsuki K., Juji T., Tokunaga K., Takamizawa M., Maeda H., Soda M., Nomura Y., Segawa M. HLA antigens in Japanese patients with myasthenia gravis. J. Clin. Invest. 86:1990;392-399.
9. Carlsson B., Wallin J., Pirskanen R., Matell G., Smith C.I. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis. Immunogenetics. 31:1990;285-290.
10. Spurkland A., Gilhus N.E., Rønningen K.S., Aarli J.A., Vartdal F. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations. Tissue Antigens. 37:1991;90-93.
11. Vieira M.L., Caillat-Zucman S., Gajdos P., Cohen-Kaminsky S., Casteur A., Bach J.F. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J. Neuroimmunol. 47:1993;115-122.
12. Khalil I., Berrih-Aknin S., Lepage V., Loste M.N., Gajdos P., Hors J., Charron D., Degos L. Trans-encoded DQ-alpha-beta heterodimers confer susceptibility to myasthenia gravis disease. C. R. Acad. Sci. Paris. 316:1993;652-660.
13. Hjelmström P., Giscombe R., Lefvert A.K., Pirskanen R., Kockum I., Landin-Olsson M., Sanjeevi C.B. Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis. Autoimmunity. 22:1995;59-65.
14. Hjelmström P., Giscombe R., Lefvert A.K., Pirskanen R., Kockum I., Landin-Olsson M., Sanjeevi C.B. Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis. J. Neuroimmunol. 65:1996;125-131.
15. Nakao Y., Miyazaki T., Ota K., Matsumoto H., Nishitani H., Fujita T., Tsuji K. Gm allotypes in myasthenia gravis. Lancet. 1:1980;677-680.
16. Oksenberg J.R., Sherritt M., Begovich A.B., Erlich H.A., Bernard C.C., Cavalli-Sforza L.L., Steinman L. T-cell receptor V alpha and C alpha alleles associated with multiple sclerosis and myasthenia gravis. Proc. Natl. Acad. Sci. USA. 86:1989;988-992.
17. Demaine A., Willcox N., Janer M., Welsh K., Newsom-Davis J. Immunoglobulin heavy chain gene associations in myasthenia gravis - new evidence for disease heterogeneity. J. Neurol. 239:1992;53-56.
18. Dondi E., Gajdos P., Bach J.F., Garchon H.J. Association of Km3 allotype with increased serum levels of autoantibodies against muscle acetylcholine receptor in myasthenia gravis. J. Neuroimmunol. 51:1994;221-224.
19. Garchon H.J., Djabiri F., Viard J.P., Gajdos P., Bach J.F. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc. Natl. Acad. Sci. USA. 91:1994;4668-4672.
20. Heckmann J.M., Morrison K.E., Emeryk-Szajewska B., Strugalska H., Bergoffen J., Willcox N., Newsom-Davis J. Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. J. Autoimmun. 9:1996;175-180.
21. Morel E., Bach J.F., Briard M.L., Aubry J.P. Neonatal myasthenia gravis. Anti-acetylcholine receptor antibodies in the amniotic fluid. J. Neuroimmunol. 6:1984;313-317.
22. Caillat-Zucman S., Garchon H.J., Timsit J., Assan R., Boitard C., Djilali-Saiah I., Bougnères P., Bach J.F. Age-dependent HLA genetic heterogeneity of type-I insulin-dependent diabetes mellitus. J. Clin. Invest. 90:1992;2242-2250.
23. Caillat-Zucman S., Garchon H.J., Costantino F., Cot S., Bach J.F. Automation of large-scale HLA oligotyping using a robotic workstation. Biotechniques. 15:1993;526-526.
24. Woolf B. On estimating the relation between blood group and disease. Ann. Eug. 19:1955;251-253.
25. Lewontin R.C. The detection of linkage disequilibrium in molecular sequence data. Genetics. 140:1995;377-388.
26. Bishop Y.M.M., Fienberg S.E., Holland P.W. Discrete Multivariate Analysis. 1975;MIT Press, Cambridge.
27. Mehta C., Patel N. LogXact-Turbo. User Manual. 1993;Cytel Software Corporation, Cambridge.
28. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium - the insulin gene region and insulin-dependent diabetes-mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
29. Begovich A.B., McClure G.R., Suraj V.C., Helmuth R.C., Fildes N., Bugawan T.L., Erlich H.A., Klitz W. Polymorphism, recombination, and linkage disequilibrium within the HLA class-II region. J. Immunol. 148:1992;249-258.
30. Campbell R.D., Milner C.M. MHC genes in autoimmunity. Curr. Opinion Immunol. 5:1993;887-893.
31. Jacobs K.H., Jenkins D., Mijovic C., Penny M., Uchigata Y., Cavan D., Hirata Y., Otani T., Fletcher J., Barnett A.H. An investigation of Japanese subjects maps susceptibility to type-1 (insulin-dependent) diabetes-mellitus close to the DQA1 gene. Hum. Immunol. 33:1992;24-28.
32. Baisch J.M., O'Brien M.E., Hoover M., Capra J.D. Analysis of HLA genotypes and susceptibility to insulin-dependent diabetes-mellitus - HLA-DQalpha complements HLA-DQbeta. Scand. J. Immunol. 36:1992;321-330.
33. Sollid L.M., Markussen G., Ek J., Gjerde H., Vartdal F., Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J. Exp. Med. 169:1989;345-350.
34. Pugliese A., Bugawan T., Moromisato R., Awdeh Z.L., Alper C.A., Jackson R.A., Erlich H.A., Eisenbarth G.S. Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes. J. Clin. Invest. 93:1994;2447-2452.
35. Yanagawa T., Mangklabruks A., DeGroot L.J. Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population. J. Clin. Endocrinol. Metabol. 79:1994;227-229.
36. Reveille J.D., MacLeod M.J., Whittington K., Arnett F.C. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J. Immunol. 146:1991;3871-3876.
37. Degli-Esposti M.A., Andreas A., Christiansen F.T., Schalke B., Albert E., Dawkins R.L. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics. 35:1992;355-364.
38. Degli-Esposti M.A., Abraham L.J., McCann V., Spies T., Christiansen F.T., Dawkins R.L. Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics. 36:1992;345-356.
39. Abraham L.J., Grimsley G., Leelayuwat C., Townend D.C., Pinelli M., Christiansen F.T., Dawkins R.L. A region centromeric of the major histocompatibility complex class I region is as highly polymorphic as HLA-B - implications for recombination. Hum. Immunol. 38:1993;75-82.
40. Marshall B., Leelayuwat C., Abraham L.J., Pinelli M., Dawkins R.L. Large transcripts and sequence from a polymorphic 170 kb MHC region implicated in susceptibility to autoimmune disease. Immunogenetics. 39:1994;15-20.
41. Julier C., Hyer R.N., Davies J., Merlin F., Soularue P., Briant L., Cathelineau G., Deschamps I., Rotter J.I., Froguel P., Boitard C., Bell J.I., Lathrop G.M. Insulin-IGF2 region on chromosome-11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature. 354:1991;155-159.
42. Dizier M.H., Babron M.C., Clerget-Darpoux F. Interactive effect of two candidate genes in a disease: extension of the marker-association-segregation chi2 method. Am. J. Hum. Genet. 55:1994;1042-1049.
43. Sinigaglia F., Hammer J. Defining the rules for peptide-MHC class II interaction. Curr. Opinion Immunol. 6:1994;52-56.
44. Hammer J., Gallazzi F., Bono E., Karr R.W., Guenot J.M., Valsasnini P., Nagy Z.A., Sinigaglia F. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1995;1847-1855.
45. Smilek D.E., Wraith D.C., Hodgkinson S., Dwivedy S., Steinman L., McDevitt H.O. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 88:1991;9633-9637.
46. Singh D.P., Kikuchi T., Singh V.K., Shinohara T. A single amino acid substitution in core residues of S-Antigen prevents experimental autoimmune uveitis. J. Immunol. 152:1994;4699-4705.
47. Karin N., Mitchell D.J., Brocke S., Ling N., Steinman L. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. J. Exp. Med. 180:1994;2227-2237.
48. Fuchs S., Mozes E. In vitro proliferative response and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J. Clin. Invest. 82:1988;1894-1900.
49. Manfredi A.A., Yuen M.H., Moiola L., Protti M.P., Conti-Tronconi B.M. Human acetylcholine receptor presentation in myasthenia gravis - DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. J. Immunol. 152:1994;4165-4174.
50. Nicolle M.W., Hawke S., Willcox N., Vincent A. Difference in processing of an autoantigen by DR4:Dw4.2 and DR4:Dw14.2 antigen-presenting cells. Eur. J. Immunol. 25:1995;2119-2122.
51. Batocchi A.P., Harcourt G., Beeson D., Pantic N., Hawke S., Willcox N., Newsom-Davis J. Differential recognition by T-cells of the P3A+ and P3A- isoforms of the human acetylcholine receptor α-subunit. Ann. N.Y. Acad. Sci. 681:1993;280-282.